Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children-Reference-Cited by-同舟云学术

Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children

Published:2020-06-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pelland-Marcotte Marie-Claude¹,Amiri Nour²,Avila Maria L²,Brandão Leonardo R²

Affiliation:

1. Institute of Health Policy, Management and Evaluation; University of Toronto; Toronto Canada

2. Division of Haematology-Oncology; The Hospital for Sick Children; Toronto Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference83 articles.

1. THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents;Greiner;Haematologica,2019

2. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial;Massicotte;Thrombosis Research,2003

3. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial;Abdelkefi;Thrombosis and Haemostasis,2004

4. Evaluating the effect of high dose versus low dose heparin in peripherally inserted central catheter in very low birth weight infants;Behzad;Iranian Journal of Pediatrics,2018

5. Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: reasons for use and incidence of bleeding complications;Cavo;Thrombosis Research,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized, Controlled Trial of Continuous Heparin Infusion to Prevent Asymptomatic Catheter-Related Thrombosis at Discharge in Infants After Cardiac Surgery: The CHIP-CRT Trial;Journal of Pediatric Hematology/Oncology;2024-06-25

2. Thromboprophylaxis to prevent venous thromboembolism in postoperative patients;Salud, Ciencia y Tecnología - Serie de Conferencias;2024-04-15

3. Prophylaxis with enoxaparin and antithrombin III in drug-induced coagulation alterations in childhood leukemia: a retrospective experience of 20 years;Thrombosis Journal;2024-03-27

4. Central Lines and Their Complications in Neonates: A Case Report and Literature Review;Children;2023-12-25

5. Flushing and locking management related to central venous catheter occlusion rate among adult patients in acute care: a best practice implementation project;JBI Evidence Implementation;2023-11-21